Get started with Myriad myPath® Melanoma
To help better understand the clinical utility of this new assay, Myriad myPath® Melanoma is being launched in a phased approach beginning with an early access program called melEvalPRO. This educational email program will guide you through the critical information you need to ensure that you have the best and most successful experience possible.
After completing the form on the right you will be contacted by a member of our dedicated customer service team to answer any questions you may have and to send you your initial test kit.
All enrollees must be an active dermatopathologist in order to start testing with Myriad myPath Melanoma.